Global Emergency Contraceptive Pills Market 2016-2020

  • ID: 3802176
  • Report
  • Region: Global
  • 48 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Allergan
  • HLL Life Care
  • Lupin Pharmaceuticals
  • Mankind Pharma
  • Pfizer
  • Piramal Healthcare
  • MORE
About Emergency Contraceptive (EC) Pills

EC pills are short-term contraceptives used in the initial days after sexual intercourse to prevent pregnancy due to various uncertainties such as unprotected intercourse, coerced sex, forgotten pills, and condom breakage. These pills are only effective before the fertilization of the ovum by the sperm. As per WHO, levonorgestrel-based EC pills are ideal for users when taken in a single dose. These pills are not effective after five days once the ovulation process begins. Factors such as urbanization, increasing acceptance of sex, and growing visibility of EC pills are increasing their penetration in emerging economies.

The analysts forecast the global EC pills market to grow at a CAGR of 1.93% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global EC pills market for 2016-2020. To calculate the market size, the analyst considers the revenue generated from the retail sales of generic and branded EC pills worldwide. However, the report does not include sales of long-term contraception methods such as birth control pills.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Emergency Contraceptive (EC) Pills Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Allergan
- Lupin
- Mankind
- Piramal
- Teva

Other prominent vendors
- HLL Life Care
- Pfizer
- Syzygy Healthcare
- V Care Pharma

Market drivers
- Increase in unplanned pregnancies
- For a full, detailed list, view the full report

Market challenges
- Counterfeit products
- For a full, detailed list, view the full report

Market trends
- Growing sales of generic brands
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Allergan
  • HLL Life Care
  • Lupin Pharmaceuticals
  • Mankind Pharma
  • Pfizer
  • Piramal Healthcare
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Geographical segmentation
  • EC pills market in Americas
  • EC pills market in EMEA
  • EC pills market in APAC
PART 07: Key leading countries

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape
  • Competitive scenario
  • Other prominent vendors
PART 14: Key vendor analysis
  • Allergan
  • Lupin Pharmaceuticals
  • Mankind Pharma
  • Piramal Healthcare
  • Teva Pharmaceuticals
PART 15: Appendix
  • List of abbreviations
PART 16: About the Author

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Overview: global EC pills market 2016-2020
Exhibit 03: Global EC pills market 2015-2020 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global EC pills market segmentation by geography 2015
Exhibit 06: Global EC pills market segmentation by geography 2020
Exhibit 07: Global EC pills market segmentation by geography 2015-2020
Exhibit 08: EC pills market in Americas ($ millions)
Exhibit 09: EC pills market in EMEA ($ millions)
Exhibit 10: EC pills market in APAC ($ millions)
Exhibit 11: Global EC pills market by region
Exhibit 12: Global EC pills market by countries 2015
Exhibit 13: Global EC pills market by countries 2015-2020
Exhibit 14: EC pills market in the US 2015-2020 ($ millions)
Exhibit 15: EC pills market in China 2015-2020 ($ millions)
Exhibit 16: EC pills market in India 2015-2020 ($ millions)
Exhibit 17: Unplanned pregnancies by region ($ millions)
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: Allergan: Key takeaways
Exhibit 21: Lupin Pharmaceuticals: Key takeaways
Exhibit 22: Mankind Pharma: Key takeaways
Exhibit 23: Piramal Healthcare: Key takeaways
Exhibit 24: Teva Pharmaceuticals: Business segmentation by revenue 2014
Exhibit 25: Teva Pharmaceuticals: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Allergan
  • HLL Life Care
  • Lupin Pharmaceuticals
  • Mankind Pharma
  • Pfizer
  • Piramal Healthcare
  • MORE
New Report Released: – Global Emergency Contraceptive (EC) Pills Market 2016-2020

The author of the report recognizes the following companies as the key players in the global emergency contraceptive (EC) pills market: Allergan, Lupin Pharmaceuticals, Mankind Pharma, Piramal Healthcare, and Teva Pharmaceuticals.

Other Prominent Vendors in the market are: HLL Life Care, Pfizer, Syzygy Healthcare, and V Care Pharma.

Commenting on the report, an analyst from the research team said: “Growing sales of generic brands will be a key trend for the market growth. Generic EC pills are increasingly being sold at different drug stores. Compared with branded EC pills, the generic EC pills are less costly and available to all with no age limit. These factors have led to increased sales of generic brands. For instance, Teva Pharmaceuticals generates the majority of its revenue from its generic brand Plan B, rather than its original brand, which is usually sold through pharmacy counters and requires a prescription for women under the age of 17. Thus, vendors are trying to implement push marketing for increasing sales and directly contribute to the revenue of the market during the forecast period.”

According to the report, rise in exploration of sexual fantasies will be a key driver for market growth. Globally, there has been an increase in the exploration of sexual fantasies. Sexual norms, behaviors, and attitudes are undergoing a transformation because of increased exposure to the internet, TV shows, and erotic literature. This has also paved the way for casual sex with multiple partners. The younger generation is embracing experimentation when it comes to sex and is aware of the protection required. This is driving the demand for EC pills in the markets as they are effective and reliable in preventing pregnancy. The shift in the attitude of consumers is evident because, despite the economic slowdown, there are new players as well as niche players in the market.

Further, the report states that doubts regarding effectiveness will be a major challenge for the market. EC pills in the market claim to be almost 100% effective if the procedure of use is followed precisely, irrespective of the time. In rare occasions, these pills fail to act, owing to delay in use or other reasons, bringing into question the reliability of the product. The results of EC pills vary on the basis of use – the sooner the user takes the pill, the more effective it is. The probability of getting effective results is high within 5 days after unprotected sexual intercourse and other uncertainties. Pills if taken beyond the given duration might not be 100% effective. Vendors in the market are working toward combating this challenge by developing more sensitive tests that can give effective results.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Allergan
- Lupin Pharmaceuticals
- Mankind Pharma
- Piramal Healthcare
- Teva Pharmaceuticals
- HLL Life Care
- Pfizer
- Syzygy Healthcare
- V Care Pharma
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll